This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M Abbey , P Clifton , M Kestin , B Belling & P Nestel Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis (1990) 10, 85–94.
MA Austin , JE Hokanson & KL Edwards Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol (1998) 81, 7B–12B.
KH Bonaa , KS Bjerve , B Straume , IT Gram & D Thelle Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med (1990) 322, 795–801.
JM Gaziano , CH Hennekens , CJ O'Donnell , JL Breslow & JE Buring (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 96 2520–2525
BA Griffin The effect of n-3 fatty acids on low density lipoprotein subfractions. Lipids (2001) 36 S91–S97
SA Grover , L Coupal & XP Hu (1995) Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?. JAMA. 274 801 – 806
SA Grover , CS Palmer & L Coupal Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch Intern Med. (1994) 154 679 – 684
HN Hodis (1999) Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 99 2852 – 2854
JE Hokanson & MA Austin (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 3 213 – 219
DR Illingworth , WS Harris & WE Connor (1984) Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis 4 270 – 275
M Inagaki & WS Harris Changes in lipoprotein composition in hypertriglyceridemic patients taking cholesterol-free fish oil supplements. Atherosclerosis (1990) 82 237 – 246
B Kinosian , H Glick & G Garland (1994) Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 121 641 – 647
HR Knapp & GA FitzGerald (1989) The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med. 320 1037 – 1043
G Lu , SL Windsor & WS Harris (1999) Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem. 10 151 – 158
YK Lungershausen , M Abbey , PJ Nestel & PRC Howe (1994) Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens. 12 1041 – 1045
GJ Nelson , PC Schmidt , GL Bartolini , DS Kelley & D Kyle (1997) The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 32 1137 – 1146
I Toft , KH Bonaa , OC Ingebretsen , A Nordoy & T Jenssen (1995) Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial. Ann Intern Med. 123 911 – 918